Orbital Therapeutics

Orbital Therapeutics

Biotechnology, 200 Technology Sq, Cambridge, Massachusetts, 02139, United States, 11-50 Employees

orbitaltx.com

  • twitter
  • LinkedIn

Who is ORBITAL THERAPEUTICS

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previ...

Read More

map
  • 200 Technology Sq, Cambridge, Massachusetts, 02139, United States Headquarters: 200 Technology Sq, Cambridge, Massachusetts, 02139, United States
  • 2022 Date Founded: 2022
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $250 Million to $500 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ORBITAL THERAPEUTICS

Orbital Therapeutics Org Chart and Mapping

Employees

Nick Snead

Associate Director, Biology and Pharmacology

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Orbital Therapeutics

Answer: Orbital Therapeutics's headquarters are located at 200 Technology Sq, Cambridge, Massachusetts, 02139, United States

Answer: Orbital Therapeutics's official website is https://orbitaltx.com

Answer: Orbital Therapeutics's revenue is $250 Million to $500 Million

Answer: Orbital Therapeutics's SIC: 2834

Answer: Orbital Therapeutics's NAICS: 561110

Answer: Orbital Therapeutics has 11-50 employees

Answer: Orbital Therapeutics is in Biotechnology

Answer: Orbital Therapeutics contact info: Phone number: Website: https://orbitaltx.com

Answer: Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previously possible. Were building a first-in-kind platform designed to sit at the intersection of RNA technology delivery methods, data science and automation to develop an expansive portfolio of medicines, initially focused in the areas of vaccines, immunomodulation, protein replacement and regenerative medicine. Founded by experts in the fields of genetic medicine and RNA development and delivery, we have a dynamic operational structure designed to harness the ingenuity of a deep and diverse team of scientists, drug developers and business leaders.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access